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Human seasonal influenza viruses evolve rapidly, enabling the virus population to evade immunity and re-infect
previously infected individuals. Antigenic properties are largely determined by the surface glycoprotein hemag-
glutinin (HA) and amino acid substitutions at exposed epitope sites in HA mediate loss of recognition by anti-
bodies. Here, we show that antigenic differences measured through serological assay data are well described by
a sum of antigenic changes along the path connecting viruses in a phylogenetic tree. This mapping onto the tree
allows prediction of antigenicity from HA sequence data alone. The mapping can further be used to make predic-
tions about the makeup of the future seasonal influenza virus population, and we compare predictions between
models with serological and sequence data. To make timely model output readily available, we developed a web
browser based application that visualizes antigenic data on a continuously updated phylogeny.
Seasonal influenza viruses evade immunity in the human
population through frequent amino acid substitutions in their
hemagglutinin (HA) and neuraminidase (NA) surface glyco-
proteins (Hay et al., 2001). To maintain efficacy, vaccines
against seasonal influenza viruses need to be updated fre-
quently to match the antigenic properties of the circulating
viruses. To facilitate informed vaccine strain selection, the
genotypes and antigenic properties of circulating viruses are
continuously monitored by the World Health Organization
(WHO) Global Influenza Surveillance and Response System
(GISRS), with a substantial portion of the virological charac-
terizations being performed by the WHO influenza Collabo-
rating Centers (WHO CCs) (Barr et al., 2014).
Antigenic properties of influenza viruses are measured in
hemagglutination inhibition (HI) assays (Hirst, 1942), that
record the minimal antiserum concentration (titer) necessary
to prevent crosslinking of red blood cells by a standardized
amount of virus based on hemagglutinating units (HAU). An
antiserum is typically obtained from a single ferret infected
with a particular reference virus. For a panel of test viruses,
the HI titer is determined by a series of two-fold dilutions of
each antiserum. An antiserum is typically potent against the
homologous virus (the reference virus used to produce the an-
tiserum), but higher concentrations (and hence lower titers)
are frequently required to prevent hemagglutination by other
(heterologous) viruses. HI titers typically decrease with in-
creasing genetic distance from the homologous virus ((Hay
et al., 2001)).
Given multiple antisera raised against different reference
viruses and a panel of test viruses, WHO CCs routinely mea-
sure the matrix of distances between a set of antisera and mul-
tiple test viruses, see Fig. 1A. This distance matrix can be vi-
sualized in two dimensions via multidimensional scaling – an
approach termed antigenic cartography (Smith et al., 2004).
While standard cartography does not use sequence informa-
tion, sequences have been used as priors for distances in a
Bayesian version of multidimensional scaling (Bedford et al.,
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FIG. 1 Antigenic data and models for HI titers. A: A typical table
reporting HI titer data. Each number in the table is the maximum
dilution at which the antiserum (column) inhibited hemagglutination
of red blood cells by a virus (row). The red numbers on the diagonal
indicate homologous titers. A typical HI assay consists of all recip-
rocal measurements of the available antisera and reference viruses,
and a number of test viruses that are measured against all antisera,
but for which no homologous antiserum exists. B: Each HI titer be-
tween antiserum α and virus i can be associated with a path on the
tree, indicated as a thick line. The tree model seeks to explain the
titer distance as additive contributions of branches. C: In the substi-
tution model, the sum over branches on the tree is replaced by a sum
of contributions of amino acid substitutions.
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22014). In order to infer contributions of individual amino acid
substitutions to antigenic evolution, Harvey et al. (2014); Sun
et al. (2013) have used models that predict HI titer differences
by comparing sequences of reference and test viruses.
Here, we show that antigenic distance relationships are ac-
curately described by a model based on phylogenetic tree
structure. We use the model to show that HI distances have a
largely symmetric and tree-like structure. We show that large
effect mutations account for about half of the total antigenic
change and the effect of specific substitutions is strongly de-
pendent on the genetic background in which they occur. We
further investigate the ability of HI measurements to predict
dominant clades in the next influenza season. To visualize
antigenic properties on the phylogenetic tree, we have inte-
grated the models of antigenic distances and the raw HI titer
data into nextflu – an interactive real-time tracking tool for
influenza virus evolution (Neher and Bedford, 2015).
This comprehensive summary of HA sequences from past
and current influenza viruses linked to their antigenic proper-
ties has the potential to inform vaccine strain selections and
facilitate efforts to predict successful influenza lineages (He
and Deem, 2010; Łuksza and La¨ssig, 2014; Neher et al., 2014;
Steinbru¨ck et al., 2014; Steinbru¨ck and McHardy, 2011).
Results
We use two related models that predict HI titers from se-
quences. The first – the tree model – expresses logarithmic
HI titers by a sum of titer drops along branches in the phylo-
genetic tree that connect the test virus and the reference virus
against which the antiserum was raised, see Fig. 1B. The sec-
ond – the substitution model – explains HI titers as a sum of
titer drops associated with amino acid substitutions between
reference and test virus, see Fig. 1C. Not all branches and
not all substitutions are expected to result in changes to titer.
These two models are similar but complement each other in
a few aspects that we discuss further below. In addition to
titer drops associated with branches or substitutions, individ-
ual antisera and viruses differ in their activity in HI assays.
In the model, we account for this variability through ‘anti-
serum potency’, which raises or lowers the expected titer of
all HI measurements against an antiserum, and ‘virus avid-
ity’, which raises or lowers the expected titer of all HI mea-
surements against a virus.
Specifically, in the tree model the antigenic distance ∆iα
between virus i and antiserum α is modelled as
∆iα = pα + ci +
∑
b∈(i...α)
db (1)
where db, pα, ci denote the titer drop on a branch b in the
path (i . . . α), the potency of antiserum α, and the avidity of
virus i, respectively. In the substitution model, the sum over
branches is replaced by a sum over amino acid substitutions
between reference and test virus. The parameters of our model
are determined by minimizing a cost function that encourages
a sparse model, i.e., a model that explains titers with a small
number of large parameters and many parameters set to zero.
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FIG. 2 HI titers are accurately predicted by the tree model. The
figure scatters predicted (y-axis) against a test set of measurements
not used for training of the model (x-axis). This test set either con-
sists of A) a random sample of 10% of all measurements, or B) all
measurements for 10% of all viruses. In the latter, no avidity of a
virus can be estimated for viruses in the test set since these viruses
are completely absent from the training data. Hence prediction accu-
racy is lower but still comparable to the measurement accuracy.
TABLE I Prediction accuracy of the tree and substitution model.
The terms titer and virus refer to predictions of individual titer mea-
surements or all measurements for viruses completely absent from
the training data, respectively.
model: tree substitution
test set: titer virus titer virus
A(H3N2) (12y) 0.54 0.72 0.53 0.71
A(H1N1pdm09) (7y) 0.46 0.77 0.5 0.72
B/Yam (12y) 0.68 0.86 0.65 0.88
B/Vic (12y) 0.74 0.86 0.76 0.84
This is achieved by `1-norm regularization and non-negativity
constraints, corresponding to the assumption that antigenic ef-
fects are positive and exponentially distributed. In contrast,
the parameters absorbing variation among virus/antisera in-
teractions are regularized by their `2-norm, corresponding to
a Gaussian prior on these parameters. For a detailed descrip-
tion of the models and inference procedures, see Material and
Methods.
The decomposition of the HI data into antiserum potency,
avidity of a virus, and a sparse genetic component (branches
or substitutions) has the effect of smoothing the HI distance
relationships and virus and antiserum specific variation is ab-
sorbed into the corresponding effects. The substitution or
branch effects pick up titer drops associated with a larger num-
ber of antiserum-virus pairs.
The tree and substitution models accurately predict HI
titers
To evaluate the performance of the models we trained them
on 90% of the data and used the remaining measurements to
validate the models as in (Bedford et al., 2014). We found that
the models were able to predict titers of antiserum-virus com-
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FIG. 3 HI titers approximate a distance on the tree. A) Recip-
rocal HI titer measurements often differ by several log2 units. After
subtracting the inferred virus and antiserum effects the remaining HI
titer distance is almost symmetric with deviations again on the order
of the measurement accuracy. B) On a tree, the two largest sums of
distances within antisera / virus quartets are equal (see text). The fig-
ure shows the distribution of the absolute value of the difference of
the top two distance sums for quartets and for three random distance
sums. Those from quartets have a much smaller deviation.
binations to an accuracy of approximately 0.5 log2 titer levels
for H3N2 with somewhat lower accuracy for the influenza B
lineages (Tab. I, Fig. 2A). Very little consistent antigenic evo-
lution is observed in A(H1N1pdm09).
To quantify the prediction accuracy for viruses for which
no antigenic data exists, we selected 10% of the viruses and
excluded all measurements involving these viruses from the
training data. Both models predicted titers for viruses not part
of the training set to an accuracy of approximately 0.75 log2
titer levels (Tab. I, Fig. 2B). Having completely excluded a
virus from the training data implies that no avidity of a virus
can be estimated. The increased prediction error is therefore
largely due to virus-to-virus variability that is not captured by
the HA phylogeny.
In order to infer the genetic component of an HI titer, the
relevant branches in the tree or the substitutions that separate
test and reference virus have to be constrained by measure-
ments in the training data set. For a completely novel clade in
the tree, the model would predict HI titers equal to that of the
base of the clade for all subtending viruses. Similarly, accu-
rate inferences by the substitution model require the effects of
the relevant substitutions to be constrained by training data.
Using the tree and substitution models, we can predict
HI titers for every combination of antiserum and virus in
a phylogenetic tree (with prediction confidence varying by
quality and amount of antigenic data), essentially providing
a smoothed interpolation of antigenic evolution on the tree.
Note that the model correctly predicts titers in excess of ho-
mologous titers (negative values in Fig. 2A). These higher
titers often coincide with large negative virus avidities, which
explains the absence of titers predicted to be strongly negative
in Fig. 2B, where no virus avidities are available.
HI titers approximate a symmetric tree distance
To further evaluate the approach of partitioning a titer into
a antiserum, a virus, and a tree component, we considered all
reciprocal titer measurements, i.e., pairs of viruses a, b against
which antisera α, β have been raised and that have been mea-
sured against each other. Subtracting the virus avidities and
antiserum potency contributions from titers, the remainders
Ha,β−ca−pβ andHb,α−cb−pα should reduce the titers to the
symmetric tree component. Fig. 3A compares the distribution
of Ha,β − ca− pβ −Hb,α + cb + pα with the uncorrected dif-
ference between the reciprocal titers Ha,β −Hb,α. While raw
reciprocal titer measurements often differ by several log2 titer
units, the corrected tree component was symmetric to within
one unit, as expected.
The degree to which titer distances have tree-like proper-
ties can be tested using the following quartet rule: take any
four leaves a, b, c, d and construct the sum of the distances
dab + dcd, dac + dbd and dad + dbc. If the distances are
given by a tree, the two largest of the three sums of distances
will be equal. To test this quartet rule we determined maxi-
mal ‘cliques’ of reference antisera, the activities of which had
been measured against all viruses used to generate the antis-
era. Out of these cliques, we selected at random four antisera,
and compared the two largest distance sums. As a control,
we constructed three sums of two distances by three times
randomly drawing four antisera. The difference between the
largest and second largest of these distance sums has a mean
of 0.41 log2 titer levels, while the control has a mean of 0.95
log2 titer levels (Fig. 3B). The similarity of the largest and
second largest sums supports a tree-like structure underlying
observed HI distances.
Amino acid substitutions associated with titer drops
The majority of antigenic evolution tends to occur at a
subset of sites (Muoz and Deem, 2005; Shih et al., 2007)
with seven positions near the HA receptor binding site (Koel
7) playing a particularly prominent role (Koel et al., 2013).
However, the number of substitutions at these sites is a poor
predictor of antigenic distance with r2 values of about 0.25
(supplementary Fig. S1), possibly because the effect of a sub-
stitutions depends on the genetic background (HA sequence)
in which it occurs.
Within the substitution model, we can explicitly associate
antigenic changes with amino acid substitutions. Tab. S1
shows the top 50 contributions for A(H3N2) for sequences
estimated from sets of sequences and the associated HI titers
in five overlapping 10 year intervals. Most of the largest con-
tributions coincide with substitutions at Koel 7 sites. When a
substitution is present in the same context in overlapping time
intervals, the estimated effects tend to be similar (K189N,
K135E, K158R, K140E, Y159F) – provided there is enough
data to constrain the model.
By and large, the effects we infer are compatible with those
associated with cluster transitions determined in (Koel et al.,
2013). For example, the transition from the Sichuan/87 (SI87)
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FIG. 4 Cumulative antigenic change from the root to the leaves
of the tree. A) shows H3N2 antigenic evolution over the past 30
years. B) shows the corresponding traces for the two influenza B
lineages (past 20 years) and H1N1pdm09 (past 7 years).
cluster to the Beijing/89 (BE89) cluster involved the substitu-
tion N145K, for which we infer an effect of 1.95 antigenic
units (each unit is equal to a two-fold decrease in HI titer).
Together with minor effects associated with N193S, I186S,
and G135N, this comes close to the map distance 3.9 units.
For the transition from SI87 to Beijing/92 (BE92), the substi-
tution model estimates a distance of 4.5 that is associated with
many almost simultaneous substitutions – hence the exact as-
signment remains difficult to pin down. The map distance
corresponding to this cluster transition is 7.8 units, while the
typical titer drop is approximately 5 units and hence closer
to the estimate of the tree or substitution model. The tran-
sition from BE92 to Wuhan/95 (WU95) is gradual with sev-
eral substitutions of intermediate magnitude. From WU95 to
Sydney/97 (SY97), we estimate a distance of approximately 3
units of which 2 units are attributed to the set of substitutions:
K62E/V144I/K156Q/E158K/V196A/N276K. These substitu-
tions account for 3.6 units in cartography. Lastly, the transi-
tion from SY97 to Fujian/02 (FU02) is attributed to Q156H
(1.05 units as in (Koel et al., 2013)) and N121T. Most of the
distances we infer between clusters are smaller than those esti-
mated in cartography, which is compatible with our finding of
overall reduced antigenic drift when modeling antigenic evo-
lution in many dimensions (see below).
The inferred effects of substitutions suggest substantial de-
pendence on genetic background and the specific amino acid
change. For HA1 position 145, the back and forth between
asparagine (N) and lysine (K) is associated with different ef-
fects in 1989–1992, and 2004. Interestingly, the inferred ef-
fect of the forward substitutions (N145K in 89–92 and K145N
in 04) is large in these instances, while the inferred effect for
the backward direction is small. Some substitutions at Koel
7 positions have very small effects, as for example E158D
and S189N which involve biochemically similar amino acids.
Other substitutions at these positions have large effects, but
don’t spread. K158R, for example, shows up repeatedly and
is associated with a 2 unit titer drop without ever reaching
high frequencies. A full table of all inferred effects for substi-
tutions at particular positions in overlapping 10 year intervals
is given as supplementary Tab. 2. However, the interpretation
of effects is sometimes difficult due to colinearities between
substitutions.
Cumulative antigenic evolution
By summing all contributions to antigenic change on
branches on the path between a virus and the root of the tree,
we can estimate the total past antigenic change. This cumu-
lative antigenic change is roughly comparable to ‘dimension
1’ in antigenic cartography (more precisely analogous to the
length of a path on the map corresponding to the trunk of the
tree). H3N2 viruses advance by approximately 0.7 log2 titer
units per year (Fig. 4A), while influenza B virus lineages ad-
vance 0.16 (Vic) and 0.09 (Yam) units per year (Fig. 4B). Al-
though consistent in relative rates across lineages, these ab-
solute rates tend to be slightly lower than estimated previ-
ously using cartography (Bedford et al., 2014), possibly be-
cause forcing the antigenic distance matrix into two dimen-
sion causes distortions resulting in a slight exaggeration of
the distances. Very little consistent antigenic evolution is ob-
served in H1N1pdm09 (Fig. 4B).
We estimate that in A(H3N2) approximately half the cu-
mulative antigenic evolution is due to a large number of sub-
stitutions with effects smaller than one unit, while 20% is ac-
counted for by a few substitutions with effects above two units
(Fig. S3). However, some of largest effects are associated with
clusters of colinear amino acid changes and their individual
effects cannot be resolved.
Limitations of the models
The tree and substitution model perform similarly in terms
of accuracy as summarized in Tab. I, which is expected since
branches of the tree are associated with substitutions and vice
versa. In particular circumstances, however, one model is
more accurate than the other and the two models complement
each other in a number of situations.
The tree model assumes that titers are additive along the
tree. While this is in general a reasonable assumption, it is
violated when the same amino acid position is mutated mul-
tiple times in different parts of the tree. In a recent example
from H3N2, there are independent substitutions at HA1 site
159 with F159Y resulting in clade 3c2.a viruses and F159S
resulting in clade 3c3.a viruses. The distance between 3c2.a
and 3c3.a viruses is not necessarily a sum of the effects associ-
ated with the branches on which these two substitutions occur.
In such cases, the substitution model tends to be more accu-
rate as it has the additional freedom to introduce the Y159S
substitution (and the reverse) that directly compares 3c2.a and
3c3.a viruses.
Similarly, the substitution model fails when the same sub-
stitution (as opposed to different substitutions at the same site)
occurred in different places on the tree in different genetic
backgrounds. For sequence ensembles covering long time pe-
riods, a substitution might have happened at different times
in different genetic backgrounds. The model will fit a sin-
gle effect, even though the effect of the substitution might be
background dependent. Furthermore, the substitution model
tends to be inaccurate when predicting titers for test viruses
that predate the reference virus. Such ‘back-in-time’ measure-
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FIG. 5 Antigenic evolution and the success of clades. A) shows trajectories of clades colored by inferred cumulative antigenic evolution
in the past 6 months on branches ancestral to the clade. The majority of the clades with very large HI effects fix, but several branches with
substantial antigenic evolution go extinct. B) shows genetic distances to the next season of nodes with maximal LBI or cHI (distance is
normalized such that the average clade has distance 1). The black line indicates the distances of the best possible pick. Predictions based on
maximal LBI and cHI are correlated, but maximal cHI is sensitive to false positives. C) shows the histogram of centered cHI of the clade
closest to the next season for each year, suggesting that successful clades tend to be antigenically advanced.
ments are underrepresented in the data, and while the forward
substitution might have a large effect assigned, the few back-
in-time measurements do not provide enough support to in-
clude the reverse substitutions into the model. The tree model
does not suffer from this problem, as effects are assumed to
be symmetric.
By and large the model accurately predicts measured HI
titers (Fig. 2) and deviations affect only isolated clades, typi-
cally when very few measurements are available to constrain
the model. The visualization described below allows a direct
side by side comparison of the two models and the measure-
ments, which makes it easy to identify such isolated inaccura-
cies.
Antigenic change and the success of clades
Antigenic changes result in viruses able to reinfect individ-
uals with immunity to previously circulating viruses. Intu-
itively, large antigenic changes should therefore be positively
selected for and rapidly spread through the virus population,
unless there is a fitness cost for the virus. We investigated the
relationship between the amount of antigenic change and suc-
cess of clades in the phylogenetic tree. Fig. 5 shows frequency
trajectories of clades reaching at least 10% at one time as es-
timated by nextflu, while color indicates the magnitude of the
antigenic change that accumulated along the ancestral lineage
over the past six months. Although large antigenic changes
appear to fix more often than small antigenic changes, there
are also several clades that evolved antigenically but failed to
spread.
For each season, we determined the clade with highest Lo-
cal Branching Index (LBI, a predictor of clade success (Neher
et al., 2014)) and the clade with the largest antigenic advance-
ment (cHI) relative to all other viruses in a season (restricted to
clades that account for at least 5% of available sequences for
the given season). For each of these clades, Fig. 5B shows ge-
netic distance to the virus population of the following season.
Antigenic advance as measured by cHI is predictive of which
lineage would dominate the following season: the distance
is significantly below the population average. Predictions by
cHI and LBI are comparable in quality and are correlated. Yet,
clades with maximal cHI are sometimes far from the future
population suggesting that a predictor based on antigenic phe-
notype alone readily generates false positives: the problem
becomes worse when smaller clades are included (threshold
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FIG. 6 Substitutions with large antigenic effect fix preferentially.
The figure shows the fraction of all substitutions that reach the indi-
cated frequency for different magnitudes of the inferred antigenic
effect of this substitution. The plot combines data from substitution
models fitted to 5 overlapping 10 year intervals from 1985 to 2015
and contains all substitutions that reach at least 10% population fre-
quency. There are few substitutions in the highest HI category – error
bars show the standard deviation over boot strap replicates of substi-
tutions.
lowered to > 1% of all sequences). Nevertheless, successful
clades tend to be antigenically advanced. Fig. 5C shows the
histogram of centered cHI for clades closest to the next sea-
son. These clades tend to have larger cHI than co-circulating
viruses. These results suggest that cHI correlates with viral fit-
ness but is not the only factor determining clade success. Sup-
plementary Fig. S2 compares the cHI of the most antigenically
advanced clade to that of the successful clade in each year.
As an alternative to clades in the tree, Fig. 6 shows the prob-
ability of a substitution reaching a maximal frequency as a
function of its inferred antigenic effect. This fixation prob-
ability increases with antigenic effect, but even substitutions
with very large effect can fail to spread – an effect which lim-
its predictive power.
Visualization of antigenic evolution
Antigenic evolution can be visualized by mapping titer dis-
tances into the plane using a variant of multi-dimensional scal-
ing (Smith et al., 2004). This two dimensional representation,
however, is not readily superimposed with the sequence evo-
lution of the viruses. Instead of squeezing the sequence evo-
lution onto the plane (Bedford et al., 2014), we map the HI
titer data onto the phylogenetic tree using nextflu (Neher and
Bedford, 2015).
The application nextflu tracks in near real time the evolu-
tion of seasonal influenza viruses and allows users to explore
recent changes at particular positions, spot rapidly growing
clades, and analyze the geographic distribution of viruses.
We have integrated the tree and sequence models of titer
data into nextflu’s Python based processing pipeline augur.
The titer data and the models are exported along with the
tree and visualized using auspice, the JavaScript based front-
A/Texas/50/2012
FIG. 7 Visualization of antigenic evolution on the tree. Tree tips
are colored by the predicted log2 titer distance relative the focal virus
(A/Texas/50/2012 in this case). The tool tip shows titers relative to
all available antisera and titer predictions as a table. Each reference
virus (grey squares) can be chosen by clicking with the mouse, upon
which the tree color is updated. Crosses indicate vaccine strains. The
tool tip shows all available measurements and the predictions by both
models, while the color averages measurements relative to different
antisera.
end of nextflu. The resulting visualization is available at
HI.nextflu.org and Fig. 7 shows a screen shot.
This web visualization allows exploration of HI distance
relative to specific antisera. All reference viruses against
which antisera have been raised are indicated by grey squares.
A focal reference virus can be chosen by clicking on one of
these squares, thereby coloring the tree by the average anti-
genic distance between viruses and antisera raised against the
focal virus. Tooltips – information boxes that pop up when
the mouse hovers over a virus – display all available mea-
surements along with the predicted titers relative to the focal
virus. The normalized and log scaled titers can be option-
ally corrected using estimates of antiserum potency and virus
avidity.
The tree can be colored either by measured titers (which are
available only for a subset of the viruses) or the predictions by
either the tree model or the substitution model. Toggling be-
tween coloring by measured and predicted titers gives an in-
tuitive visual impression of the noise in titer data and possible
inaccuracies of the model predictions. The model predictions
are essentially de-noised antigenic distances that integrate in-
formation from a large number of titer measurements.
In addition to titer measurements and titer predictions, the
HI.nextflu.org website allows coloring of the tree by
the antigenic evolution that accumulated along branches start-
ing from the root of the tree. The latter is similar to dimension
one in antigenic cartography.
7Discussion
We have shown that antigenic evolution of seasonal in-
fluenza viruses can be accurately predicted from HA se-
quences using models parameterized by branches separating
test and reference virus in a phylogenetic tree or by amino
acid substitutions separating the two sequences. Both of these
models predict titers with similar or better accuracy than more
traditional cartographic approaches. The appeal of antigenic
cartography (Smith et al., 2004) is partly the ease with which
complex tables of HI titer data can summarized, visualized,
and printed on paper. To achieve similarly intuitive display
of the results of the tree and substitution models, we imple-
mented a web-browser based interactive visualization avail-
able at HI.nextflu.org (Neher and Bedford, 2015). The
web application integrates antigenic relationships with molec-
ular evolution, geographic distribution, and predictors of clade
growth. Our goal, rather than simply predicting antigenic
data from genetic sequences, was a characterization of anti-
genic space, a full integration with the phylogenetic tree, and
an assessment of the predictive value of HI measurements.
In contrast, Harvey et al. (2014) focus on identifying spe-
cific residues in H1N1 that are responsible for titer drops,
while (Sun et al., 2013) focus on predicting titers of unknown
viruses visualized via cartography.
Previous analysis had concluded that two dimensions pro-
vide the optimal embedding for antigenic evolution and
adding additional dimensions did not improve the predictive
power (Bedford et al., 2014; Smith et al., 2004) Here we find
that a model based on the tree structure – effectively infinite
dimensional – predicts titers similar or better accuracy. This
apparent discrepancy has its roots in the number of parameters
necessary to specify the model. In d dimensional cartography,
the location of each virus is described by d coordinates. Hence
the number of parameters increases rapidly with the number
of dimensions of the model and predictive power decreases
due to overfitting. However, if distances are additive and tree-
like, all n(n− 1)/2 pairwise distances between n viruses are
defined by the contributions of at most n − 2 internal and n
external branches (external branches are not considered by the
model). In practice, the number of internal branches is sub-
stantially lower than n− 2 due to the many polytomies in the
tree. For A(H3N2) from the past 12 years, HI data was avail-
able for 1796 out of total of 2473 viruses in the tree. Of the
622 internal branches constrained by HI data, 189 branches
were inferred to affect HI titers (¿0.001). Hence with sub-
stantially fewer parameters, we achieve a better or compara-
ble fit to the data than d = 2 cartography, which suggests
that the phylogenetic tree is a more natural space for antigenic
change. We corroborated this interpretation by explicitly test-
ing “tree-ness” using quartet distances and symmetry between
reciprocal measurements (Fig. 3).
We find substantial differences in the overall rate of anti-
genic evolution across viruses with fast antigenic drift in
H3N2 and slow antigenic drift within both influenza B lin-
eages, in agreement with Bedford et al. (2014). Overall, anti-
genic drift estimated by our method tends to be somewhat
lower, in particular for influenza B. This discrepancy in drift is
likely due to the different model space: the phylogenetic tree
provides more freedom for different clades to evolve in differ-
ent directions and antigenic distances are accommodated on
side branches, rather than the trunk. On a two dimensional
antigenic map, however, the space for side branches and sub-
clusters is limited, such that more antigenic distance is picked
up by the backbone of the map.
Current efforts to predict the evolution and dynamics of
seasonal influenza viruses (He and Deem, 2010; Łuksza and
La¨ssig, 2014; Neher et al., 2014; Steinbru¨ck et al., 2014;
Steinbru¨ck and McHardy, 2011) are based solely on virus
HA sequences. By mapping the phenotypic HI data onto se-
quences and phylogenetic trees, it should be possible to im-
prove prediction accuracy. Using HI data to predict is, how-
ever, not as straightforward as it might seem and by itself it
does not predict better than the sequence-based LBI predictor
(Neher et al., 2014). HA substitutions associated with large
antigenic changes have a higher probability of fixation, but
many causing substantial antigenic change (e.g. K158R) fail
to spread in the population. Similarly, in many years clades
that are antigenically more distant from previously circulating
viruses die out. The high frequency of such “false positives”
interferes with the use of HI measurements for early detection
of emerging strains that are the likely founders of future gen-
erations of the virus. We observe substantial false positives at
the 1% clade frequency level, but fewer false positives at the
5% frequency level (Fig. 5B). However, using a 5% frequency
threshold loses much of the early detection capacity, limiting
HI-based prediction to the regime accessible to the sequence-
based genealogy approaches, such as LBI.
The main challenge is hence to find a way to reduce the
false positive rate in HI-based prediction. Success of strains
with smaller HA antigenic advancement over the ones with a
larger advancement could be rationalized in two ways: i) by
some alternative improvement of infectivity, immune system
avoidance or lower mutational load; ii) by a fitness cost associ-
ated with a large antigenic effect substitutions. Supporting the
second scenario, it is known that adaptive mutations are some-
times not tolerated in certain genetic backgrounds because
they destabilize the encoded protein and further, stabilizing,
mutations are required to compensate for the loss of virus
fitness (Gong et al., 2013; Thyagarajan and Bloom, 2014).
Better understanding of the context dependence of large anti-
genic effect HA substitutions may therefore be a promising
way towards reducing the false positive rate and improving
prediction capacity. The problem of false positive detection is
also seen at the Koel 7 positions. While most past dramatic
changes in antigenic phenotype are associated with substitu-
tions at these sites, substitutions at Koel 7 sites do not always
have antigenic effects or fail to spread. Koel 7 substitutions
alone are poor predictors.
In conclusion: our study demonstrates that HI data inte-
grates naturally onto the sequence derived phylogeny of the
virus. While at present HI-based prediction does not outper-
form sequence based methods, better understanding of genetic
context dependence of HI data may provide a way towards
improved performance. Characterizing HA substitutions that
have historically been associated with antigenic transitions
8and placing HI data directly into genealogical context may
also help with optimizing targeted acquisition of HI data.
Materials and Methods
Data
HA sequences of influenza A and B viruses isolated
from humans were downloaded from GISAID. Accession
numbers of all sequences are provided as supplemen-
tary files. We collected HI data from publications Barr
et al. (2010); Russell et al. (2008); Smith et al. (2004)
and annual and interim reports of the WHO CC London
between 2002 and 2015 (Hay et al., 2008, 2009, 2002;
McCauley et al., 2011, 2010a,b, 2012a, 2013a,b, 2014a,b,
2015, 2012b). HI data prior to 2011 was curated in Bed-
ford et al. (2014)). Original HI data tables are available
from the website of the Worldwide Influenza Centre at
the Francis Crick Institute at http://www.crick.ac.
uk/research/worldwide-influenza-centre/
annual-and-interim-reports/.
While the modalities of HI assays have changed over the
years (red blood cells from different species, addition of neu-
raminidase inhibitors, etc), we find that the model describes
data spanning many years with reasonable accuracy. This
insensitivity of the model is likely due to the fact that dif-
ferences in HI assay methodologies can largely be absorbed
in the model terms for antiserum potency and virus avidity.
However the most recent data, largely provided by WHO CC
London, is modeled with greater accuracy.
Data processing and model fit
The data processing pipeline is based on nextflu (Neher and
Bedford, 2015), which subsamples viruses, aligns sequences
and builds a phylogenetic tree. This pipeline was modified for
the current purpose to enforce the inclusion of all strains for
which antigenic data was available. Then, in addition to the
standard augur pipeline of nextflu, the tree and substitution
models were fitted to the HI data as follows.
For each combination of virus i and antiserum α, we define
antigenic distance as Hi,α = log2(Taα) − log2(Tiα), where
Tiα is the antiserum titer required to inhibit virus i and Taα
is the homologous titer. In case multiple measurements are
available, we average the base 2 logarithm of the titers. When
no homologous titer was available, the maximal titer was used
as a proxy for the homologous titer. The path between virus
i and antiserum α extends over branches of the phylogeny
b ∈ (i . . . α), where each branch has a branch effect db. The
tree distance ∆i,α between virus i and antiserum α is defined
in Eq. (1). The parameters db, pα, ci are then estimated by
minimizing the cost function
C =
∑
i,α
(Hi,α−∆i,α)2+λ
∑
b
db+γ
∑
i
c2i +δ
∑
α
p2α (2)
subject to the constraints db ≥ 0. To avoid overfitting, the dif-
ferent parameters of the model are regularized by the last three
terms in Eq. (2). Large titer drops are penalized with their ab-
solute value multiplied by λ (`1 regularization), which results
in a sparse model in which most branches have no titer drop
(Candes and Tao, 2005). Similarily, the antiserum and virus
avidities are `2-regularized by γ and δ, penalizing very large
values without enforcing sparsity. This constrained minimiza-
tion can be cast into a canonical convex optimization problem
and solved efficiently, see below. In the substitution model,
the sum over the path in the tree is replaced by a sum over
amino acid differences in HA1. Sets of substitutions that al-
ways occur together are merged and treated as one compound
substitution. The inference of the substitution model parame-
ters is done in the same way as for the tree model (see Harvey
et al. (2014); Sun et al. (2013) for a similar approach). Since
there are only a small number of antisera and differences in
antiserum potency are often on the order of one or two anti-
genic units, δ was assigned a small value of 0.3, while λ = 1.0
was used to regularize branch or substitution and γ = 2.0 for
virus effects. The quality of the fit depends weakly on these
parameters.
The total number of adjustable parameters are S antiserum
potencies, V avidities of viruses, and M internal branches of
the tree of which there are at most V − 1, but typically fewer
due to many polytomies in the trees. In practice only a frac-
tion of the branches have non-zero branch effects and the total
number of non-zero parameters is not much larger than the
number of test viruses. In the substitution model, the number
of non-singleton substitutions found in an HA1 alignment is
typically on the order of 100, most of which are inferred to
have no antigenic effect.
This optimization of Eq. (2) can be cast into a canonical
quadratic programming problem of the form
minimize : 12xQx + qx (3)
subject to : Gx ≤ h
where x is the vector of unknowns, and the matrix Q and
the vector q specify the cost function. The matrix G and the
vector h encode inequality constraints on x.
To formulate Eq. (2) in this canonical form, we concate-
nate the titer drops db associated with branches b of the tree,
the potencies pα of each antiserum, and avidities ci of virus
isolates into a single vector x
xs =

ds, for s = 1 . . . B
cs, for s = B + 1 . . . B + V
ps, for s = B + V + 1 . . . B + V + S
(4)
where B are the number of branches in the tree connecting
measurements, V is the number of viruses with titer measure-
ments, and S are the number of antisera. Next, we construct a
large binary matrix A of dimension N × (B+V +S), where
N is the total number of measurements. Each row of the ma-
trix A codes for a titer prediction ∆iα. Using the double index
iα to label measurements, entries of A are given by
Aiα,s =
{
1, for s in path, potency, or avidity
0, otherwise
(5)
9i.e., Aiα,s = 1 for all s that correspond a branch of the path
(i . . . α), the virus avidity ci and the antiserum potency pα;
otherwise, Aiα,s = 0. All titer predictions of Eq. (1) are
hence given by
∆ = Ax (6)
where x is the vector of parameters.
Using these definitions, the cost function Eq. (2) can be
written as
(H−Ax)T (H−Ax)+2λ
B∑
s=1
xs+γ
B+V∑
s=B+1
x2s+δ
B+V+S∑
s=B+V+1
x2s
(7)
subject to xs ≥ 0 for s = 1 . . . B. Dropping constant terms
and defining
Qrs =

∑
iAirAis, if r, s ≤ B
γ if r = s, s > B, s ≤ B + V
δ if r = s, s > B + V
0 otherwise
(8)
we have
xQx− 2HAx + 2λ
B∑
s=1
xs (9)
To enfore the `1 regularization and the positivity of the titer
drops corresponding to xs, s = 1 . . . B, we define inequality
constraints
xs ≥0 (10)
for s = 1 . . . B which forces all titer drops to be positive. In
addition, we set
q = −HAx (11)
and add λ to qs, s = 1, . . . B to penalize large effects. With
these definitions, we have cast Eq. (2) in the form of Eq. (3).
The resulting quadratic programming problem is then solved
with cvxopt by M. Andersen and L. Vandenberghe.
The HI titer data and the inferred model parameters are inte-
grated into the json data structure describing the tree or saved
in an additional data file for later visualization using auspice.
Visualization
The HI titer coloring and tool tips is implemented via
straightforward extension of nextflu/auspice functionality. In
addition to the standard nextflu tree display, a structure show-
ing the positions at which the substitution model inferred large
contribution to antigenic change are shown on the pages for
each individual virus lineage. The structures are visualized
with JSmol (JSmol developers, 2015). For H3N2, we use
structure 5HMG (Weis et al., 1990), for H1N1pdm we use
4LXV (Yang et al., 2014), for the influenza B Victoria and
Yamagata lineages we use 4FQM (Dreyfus et al., 2012) and
4M40 (Ni et al., 2013).
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substitutions 85 to 95 90 to 00 95 to 05 00 to 10 05 to 16
K189N — — — 3.44 2.65
K158N/N189K — — — 2.17 3.25
K156E — 3.18 — — —
C1∗ — 3.03 — — —
S262N — 2.61 0.0 — 0.04
K135G 1.9 2.17 — — —
C1R∗ — 2.1 — — —
K158R — — — 1.91 2.08
C2∗ — — 1.94 — —
N145K 1.88 0.01 0.42 0.5 —
K193N 1.67 — — — —
K140E — — 1.65 1.41 —
H155Y/R189K 1.57 — — — —
T135G — 1.55 — — —
K145N 0.47 0.0 1.53 1.18 —
S133D/E156K — 1.49 — — —
S157L 0.47 0.79 — — 1.4
Y155H/K189R 1.4 — — — —
K135T — 1.37 — — —
S193F/D225N — — — 1.35 —
T212A — — — 1.27 0.62
C3∗ 1.24 — — — —
N144K — — — 1.24 0.0
K144D — — — — 1.23
N121T — — 1.21 — —
K62E/N276K — — 1.19 — —
S159Y 1.17 — — — 0.83
S133D 1.17 — — — —
S193N 1.16 — 0.56 0.0 —
L226V — 0.19 1.13 — —
S189R — 1.1 — — —
G186S — — 1.07 — —
E190D 0.0 1.06 — — —
K135E 1.04 1.05 — — —
Q156H — — 1.04 0.67 —
K144N — — — — 1.03
T135K — 0.0 1.01 — —
Y159F — — 1.01 0.9 0.0
I112V/S193F — — — — 1.01
T212S — — — — 1.0
K140I — — — 0.74 1.0
K135D — 0.99 — — —
K156E/D190E 0.97 — — — —
F159Y — — 0.17 0.34 0.97
C4∗ — — 0.97 0.27 —
D172G/Q197R/N278S 0.96 — — — —
T214I 0.11 0.91 — — —
R189S 0.9 0.7 — — —
K156H — — 0.9 — —
L157S/S189R 0.89 — — — —
TABLE S1 The 50 largest inferred antigenic effects of substitu-
tions in HA1 for A/H3N2 in the past 30 years as inferred by the
substitution model in overlapping 10 year intervals. When several
substitutions always occurred together, a combined effect is shown.
A dash indicated the absence of the substitution in a particular time
interval. The substitutions are sorted by the maximum across time
intervals. ∗ C1: E62K, N121T, S124G, N133D, R142G,
I144V, Q156K, K158E, A196V, K276N; C1R: K62E,
V144I, K156Q, E158K, V196A, N276K, i.e., largely the
reverse of cluster C1; C2: S124G, N133D, I144V, Q156K,
K276N a subset of cluster C1; C3: K82E, E83K, A131T,
R299K; C4: I25L, Q75H, T131A, T155H.
.
12
FIG. S1 Correlation of HI titer measurements (y-axis) with epitope distance between test and reference virus, distance at receptor binding
sites, and the genetic component of the substitution model. Titer measurements are corrected by antiserum potency and virus avidity. Neither
amino acid, epitope, or RBS distance explain much of the titer variation.
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FIG. S2 The in many years, the most antigenically advanced clade is not the clade dominating the next season. The figure shows the maximally
observed centered cHI vs the centered cHI of the successful clade for each year from 1990 to 2014.
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FIG. S3 About half of antigenic change is attributed to mutations with effects smaller than one unit. The figure shows the fraction antigenic
change by common mutations with effects smaller than the cutoff on the horizontal axis.
